30 Jan 2014 10:52
Press Release
For immediate release
30 January 2014
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Notice of dividend
The Directors have approved a quarterly dividend of 1.45p per ordinary share in respect of the period 1 October 2013 to 31 December 2013. The Directors expect, subject to unforeseen circumstances, to pay dividends totalling 5.8p per Ordinary Share in respect of the financial year ending 30 September 2014. The dividend will be paid on 31 March 2014 to ordinary shareholders on the register as at 14 February 2014 (the "Record Date"). The corresponding ex-dividend date will be 12 February 2014.
The Company is offering qualifying shareholders the opportunity to take new ordinary shares in the Company, credited as fully paid, in lieu of the cash dividend to be paid on 31 March 2014, by participating in the Scrip Dividend Scheme (the "Scheme") previously put in place by the Company on 5 May 2010.
The option to participate will be available to shareholders until 7 March 2014 (the "election date"). Further information on the Scheme, together with a copy of the Scheme Document (which contains the terms and conditions of the Scheme) and relevant mandate form document, is available for inspection at the National Storage Mechanism (http://www.morningstar.co.uk/uk/nsm), or through the Scrip Dividend portal on the Company's website http://www.medicxfund.com/scrip).
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
MedicX Group +44 (0) 1483 869 500
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
Canaccord Genuity Limited +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Sophie McNulty
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 124 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 28 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.